Home

Ageing is a fundamental contributor to a variety of human pathologies, such as frailty, cancer, and many neurodegenerative diseases including Alzheimer’s disease. The global elderly population is projected to substantially increase in this century; by the year 2100, 25% of the world population will be over 65 years old. This represents an international concern because of the severe socioeconomic and healthcare challenges associated with ageing. The Evandro Fang Lab is located in the Faculty of Medicine, University of Oslo and its affiliated Akershus University Hospital. We are fascinated with exploring the basic molecular mechanisms of human ageing and age-related diseases, with the final goal being the development of interventional strategies to improve people’s lifespan and healthspan. Follow up the latest news and our ageing researchers through Our Twitter (@TheFangGroupUiO), No-Age twitter (@NoAge100), and No-Age Center network (www.noage100.com).

A quick glimpse of the Fang lab
1. A video on what we are doing: here
2. Greetings from the Fang lab members on our award from the King of Norway: video (you can not miss it)
3. Summaries of the 1st (video) and 2nd (video) Norway-UK meeting on ageing and dementia
4. The 6th Anniversary video of the Fang Lab (made by Christoffer Ravneberg): video, One Day in the Fang Lab
5. The 2024 Fang lab retreat (a 2-min video).

The Fang lab is an LGBTQ friendly society.

Conflict of Interests
EFF is a co-owner of Fang-S Consultation AS (Organization number 931 410 717) and NO-Age AS (Organization number 933 219 127); he has an MTA with LMITO Therapeutics Inc (South Korea), a CRADA arrangement with ChromaDex (USA), a commercialization agreement with Molecule AG/VITADAO, an MTAs with GeneHarbor (Hong Kong) Biotechnologies Limited, and a data license option agreement with Hong Kong Longevity Science Laboratory (Hong Kong); he is a consultant to MindRank AI (China), NYO3 (Norway), AgeLab (Vitality Nordic AS, Norway), and Hong Kong Longevity Science Laboratory (Hong Kong).